A retrospective series reviewing 28 cases of optic glioma in childhood is reported from the Columbus Children's Hospital. The literature is reviewed from a clinical and pathological standpoint; in the pathological literature there is support for consideration of these lesions as a neoplastic entity, but none for designation of these gliomas as "hamartomas." An approach to the management of optic gliomas is presented. Treatment should be tailored to the individual patient; no clear therapeutic protocol appears to be supported by available data.
M
ANAGEMENT of childhood optic gliomas is controversial. There have been advocates of various combinations of surgery, observation, radiation, and corticosteroid therapy throughout the decades. Factors involved in formulating treatment regimens have included: 1) the pathological nature of the process; 2) the "natural history" of the growth; 3) the prognostic relationship to anatomic tumor location; 4) the role of hydrocephalus; and 5) factors associated with acute changes in visual morbidity.
We have reviewed retrospectively the Columbus Children's Hospital experience with 28 cases of childhood optic gliomas and have collated relevant literature contributions toward management. There appears to be no clear doctrinaire approach to treatment of such a multifactorial problem.
Summary of Cases
The records of 28 patients with optic gliomas seen between 1954 and 1975 were reviewed. A search through the medical and autopsy records included all diagnoses concerning optic nerve tumors or gliomas, optic gliomas, chiasmatic tumors or gliomas, and hypothalamic tumors or gliomas. All those without tumor in the optic apparatus were excluded.
The presenting ages were similar to those in most previous studies (Table 1) . Twenty-three of the 28 patients presented at 10 years or less. There were 12 males and 16 females. The most frequent initial complaints were loss of vision, headaches, and proptosis (Table 2) . Strabismus occurred in the majority of the youngsters below the age of 10 years who had significant visual loss. Four patients presented with clinical hypothalamic involvement (diabetes insipidus or diencephalic syndrome). There was no surgical mortality in this series and range of follow-up study was from 1 to 20 years. Presently 23 patients are living, four are dead, and two have been lost to follow-up study.
Of the 28 cases, 22 were histologically verified. Of the remaining cases, one was verified by contrast ventricular study and five cases by direct surgical observation without biopsy (optic foramen bony decompression was done when it appeared indicated). The anatomical breakdown of tumor involvement and mortality is shown in Table 3 . The one case diagnosed by x-ray study was a chiasmal-hypothalamic tumor. Of the five patients diagnosed by surgical observation without biopsy, four cases were chiasmal tumors and one was a chiasmal-hypothalamic tumor. All unilaterally involved optic nerves were resected during craniotomy or by a combination of craniotomy and the Kr6nlein orbital approach. Radiation therapy was instituted in 13 of the 28 cases (Table 4) .
Neurofibromatosis occurred with optic gliomas in 36% of cases (Table 5 ). These patients ranged in age from 2 to 15 years at diagnosis. One patient with unilateral optic nerve glioma has been lost to follow-up study. One patient with presumed unilateral optic nerve glioma has lost vision in his remaining eye over the last 13 years. No radiation therapy was given to either of these two patients. Of seven patients with chiasmal glioma and neurofibromatosis, two died and one is known to have lost further vision in the intervening years. Three of the other four patients have had stable visual acuities; the fourth patient now has very poor vision but no initial examination was made for comparison. Two of these seven patients were given radiation therapy, and followed for 6 years and 13 years, respectively. Five patients received no radiation therapy, and one of these died 7 years after biopsy of a chiasmal tumor. This patient also had retarded milestone development in the absence of hydrocephalus; the cause of death was presumed tumor progression. One patient had radiation therapy and died of a malignant peripheralnerve tumor with poor but probably stable visual acuity over 13 years of survival. Three patients who did not have radiation therapy have had stable vision over follow-up periods of 4, 5, and 18 years, respectively. One patient with a chiasmal-hypothalamic tumor and radiation therapy has very slowly decreasing vision in the left eye over a follow-up period of 10 years.
There were 18 patients who had optic gliomas without evidence of neurofibromatosis (Table 6 ). Eight of these patients had unilateral optic nerve gliomas. All unilaterally involved nerves were resected. One patient has been lost to follow-up study, and seven have stable normal vision in the remaining eye. Of eight patients with chiasmal *CF = count fingers; LP = light perception; NLP = no light perception; OD = right eye; OS = left eye.
glioma and no phakomatosis, two received no radiation therapy; one of these died and the other has stable vision. Of six patients who received radiation therapy, two have had progressive visual loss and four patients have stable vision. One of these patients with stable vision was given radiation therapy and a ventriculoatrial shunt 14 years after diagnosis because of progressive tumor obstruction of the anterior third ventricle. She has now been followed a total of 2 1 years. Of two patients with chiasmal-hypothalamic gliomas without phakomatosis, one has stable vision after 12 years, and one patient has died from tumor progression 5 years after diagnosis. Both received radiation therapy. Eight patients had hydrocephalus and optic gliomas. Five cases were due to tumor obstruction (all without neurofibromatosis), and three cases were due to aqueductal stenosis (all with neurofibromatosis). Two of the five patients with hydrocephalus due to tumor in the third ventricle have died. The other six patients treated for hydrocephalus are alive.
Discussion
Optic gliomas remain a rare and controversial entity in the spectrum of childhood intracranial tumors. Over the decades there have been many excellent reviews of the literature? '15,18,s1'34'59 but no present uniform therapeutic approach exists. Indeed, there is much disagreement over factors involved in the basic disease process itself. These factors have included: 1) the pathological nature of the process; 1'2'11'15'18'31'34'3e'49'53'57'58'63 2) the "natural history" of the growth; 23,29' 41,82 3) the prognostic relation of specific anatomic tumor location; 4x 4) the role of hydrocephalus; x1,~8,29 and 5) factors associated with acute changes in visual morbidity. 1,42,44,51,e2 A discussion of these factors might serve to form a more rational approach in critically analyzing published therapeutic protocols.
In this series, as in virtually all previous series, 11,x6,2~ optic gliomas occurred in children predominantly in their first decade of life. Visual morbidity (visual loss and/or proptosis) topped the list of presenting symptoms. Overall mortality was low when measured over one or two decades, and yon Recklinghausen's disease was a well known associated entity (36% in this series)? ~'Se There was no operative mortality, and radiation therapy was reserved predominantly for chiasm and chiasm-hypothalamic tumors. Strabismus and nystagmus were found most '63 The well differentiated pilocytic nature of the tumors (except for the very rare oligodendroglioma) with microcystic changes and scattered Rosenthal fibers ("cytoid bodies") 57,5s have been well described. More importantly, the uniform descriptions of actual tumor invasion of the pia with extension into the subarachnoid space form the most basic neuropathological requisite for an invasive, potentially progressive neuropathological process. Even Hudson, 8a who considered optic gliomas as "gliomatous degeneration," meticulously described this transpial invasion of the subarachnoid space.
In addition, there is some evidence that the midline and paramedian pilocytic gliomas represent the same cytological entity, whether located more anteriorly in the visual apparatus or more posteriorly in the brain stem or cerebellum. 6s Further, some tissue culture data tend to confirm this cytological opinion? e,27,32 Certainly pathological data provide no basis for inclusion of optic gliomas as hamartomas.
Mode of spread is also to be included in a description of the pathological process and natural history. Several theories have been advanced. Local invasion and spread, 4~,49 as with other pilocytic gliomas, appears a reasonable proposal. Verhoeff 57,58 felt there was contiguous activation by tumor of normal neighboring glial elements into neoplastic cells, rather than replication and invasion by existing tumor cells. Others present evidence that the neoplastic process might be potentially multicentric in origin? 2,15,52 Rare concomitant multicentric central nervous system gliomas with optic gliomas have been described, ~5' 4s as has the very rare ventricular spread of a primary optic glioma. 55 The "natural history" of the tumor remains problematical. Tumor progression and death in the absence of hydrocephalus, or with treated hydrocephalus, is a well documented entity? ,~~ The other side of the coin has investigators stressing the relative stability of optic perimetry and acuities in many cases. 2s
As early as 1912, Hudson s~ stated that he was unaware of any local orbital recurrence after partial intraorbital excision of optic gliomas. Much emphasis has been placed on this among those advocating the non-neoplastic nature of the tumor. In fact, the more important implication of intracranial extension of tumor was documented in a review 45 of Hudson's series; almost one-third (15 of 51 cases) of these incomplete removals described by Hudson had autopsy evidence of intracranial extension, and another nine cases had clinical evidence of intracranial extension although autopsy data were not available. The caution of potential intracranial exten-D. C. Oxenhandler and M. P. Sayers sion was raised as early as 1901. 8 In addition, there have been well documented reports of orbital recurrences over the subsequent decades since Hudson's initial report. 18,ss,5~, 55 It seems more appropriate to follow the natural history of optic gliomas in terms of decades rather than months or years, a precedent established with other childhood pilocytic tumors. 3'4'7'a'13'18'22'24'25'38'39'47'48 '50 The proclivity to slow evolution does not imply a necessarily stable, non-progressive process.
Death resulting from optic gliomas involves either tumor infiltration, untreated hydrocephalus, or, rarely, malignant degeneration, 8,8a or hemorrhage into the tumor? ~ Previous reports have emphasized the more ominous prognosis associated with more posteriorly anatomically placed gliomas. 41 Anterior unilateral optic nerve gliomas have more room to grow. Posterior hypothalamic involvement results in infiltration of vital centers over an earlier time frame. The cytology remains benign. The lesions become malignant by location, a factor well recognized. Malignant degeneration of childhood optic gliomas is a well documented but rare event. 8,81 The potential for malignant degeneration is more typical of the adult optic glioma? ~ Hydrocephalus in this series was associated with either actual tumor obstruction (five cases) or concomitant aqueduct stenosis (three cases). It is interesting that all three cases of patients with von Recklinghausen's disease had aqueductal stenosis as an etiology for their hydrocephalus. The previously reported ominous implication of hydrocephalus aa,~s,~8 with optic gliomas was not verified in this series.
Relatively rapid changes in visual morbidity are well documented. 5~,5~,8~ Spontaneous improvement in acuity is also noted to occur, x8,44,55 Mucinous pathological changes are typically well described in the tumors, ~,52 but their relation to a dynamic and sudden clinical change in visual function is uncertain. The potential role of hemorrhage within the tumor is also not well worked out. The vagaries of spontaneous decline and improvement in function obscure analysis of follow-up treatment data. 48 With this background the management of optic gliomas can pragmatically approach two anatomic categories: 1) the therapy of unilateral optic nerve gliomas, and 2) the therapy of those with chiasmal or more extensive posterior involvement.
In the management of unilateral optic nerve gliomas those children with good vision and little or no proptosis present a further therapeutic problem. Can these children be followed without surgery if meticulous neuroophthalmological follow-up studies can be performed? Age is certainly a factor, as perimetry and reliable acuities are often impossible in the young child. In addition, Lloyd 33 and Udvarhelyi, et al., 5e both report patients with progressively enlarging optic foramina (presumptive evidence of biological tumor progression) in the presence of stable follow-up visual acuities. Further, the conservation of visual acuity through intermittent steroid therapy or operative optic sheath "lysis" unfortunately tells us nothing about the inherent potential biological activity of the tumor.
We favor surgical resection of the unilateral optic nerve glioma in the young patient in whom follow-up examination is unreliable, unilateral visual loss profound, or proptosis excessive. An orbital resection would of course first require radiological proof (orbital computerized axial tomography (CT) and fractional polytome pneumoencephalography) of lack of chiasmal involvement, lest an unnecessary resection be entertained. Involvement of the central end of the optic nerve resected would require an intracranial inspection of the remaining nerve and resection, if feasible. Alternatively, a transfrontal orbital approach 14a8 could be used for the primary resection, sparing the globe for cosmetic purposes.
The approach to chiasmal involvement is both diagnostic and therapeutic. Recent advances in fractional polytome pneumoencephalography and CT scanning should do much to eliminate many of the diagnostic craniotomies. If, however, there is any question as to the origin of an anterior hypothalamic tumor, exploration should be undertaken to rule out the possibility of a tumor other than an optic glioma, such as a meningioma, teratoma, craniopharyngioma, 5 suprasellar germinoma (ectopic pinealoma), or a dermoid cyst.
The role of radiation therapy in chiasmal optic gliomas remains uncertain. Certainly regression of mass and improvement in visual acuity have been documented, u,17,18,35,5~,8~ Glaser, et al., 2s questioned the usefulness of radiation therapy, pointing to the stability of long-range follow-up acuities and perimetry in both their radiation-treated and untreated series. The series is retrospective, and included five out of 10 patients in their radiation-treated series who had clinical hypothalamic involvement at the time of inclusion in the series. Qnly two of 10 patients of the untreated group had clinical hypothalamic involvement. Comparison of these two groups is difficult.
Presently we are inclined to follow patients with chiasmal gliomas with close neuroophthalmological studies. Any evidence of field decline or visual acuity decrease might be an indication for radiation therapy. Hypothalamic involvement would, we feel, be an indication for radiation therapy. Chemotherapy has been only rarely employed in this series. Hydrocephalus is symptomatically treated with a shunting procedure (after x-ray diagnosis of the etiology of hydrocephalus) should increased intracranial pressure supervene.
Individualization of patient care is a necessity when confronted with such a rare tumor of indeterminate natural history (of potential multidecade duration). Indeed, rigid therapeutic protocols appear unsupported by available data.
We feel the sum of available pathological evidence supports the concept that optic gliomas are a potentially progressive neoplastic entity, at best one of slow subclinical progression, at worst one of relentless hypothalamic infiltration or, rarely, malignant degeneration.
